These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22776144)

  • 21. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
    Yang G; Guo L; Jin H; Li J; Ding H
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.
    Sen LQ; Berg WA; Hooley RJ; Carter GJ; Desouki MM; Sumkin JH
    AJR Am J Roentgenol; 2016 Nov; 207(5):1132-1145. PubMed ID: 27532153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
    Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
    Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
    Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
    Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
    Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
    Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
    Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.
    Visscher DW; Wallis TL; Crissman JD
    Cancer; 1996 Jan; 77(2):315-20. PubMed ID: 8625240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.
    Tazaki E; Shishido-Hara Y; Mizutani N; Nomura S; Isaka H; Ito H; Imi K; Imoto S; Kamma H
    Pathol Int; 2013 Jun; 63(6):297-304. PubMed ID: 23782331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
    Maluf H; Koerner F
    Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
    Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Baldetorp B; Linden T; Hansen B; Andersen J
    Breast Cancer Res Treat; 2000 Apr; 60(3):219-26. PubMed ID: 10930109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ.
    Miller ME; Muhsen S; Zabor EC; Flynn J; Olcese C; Giri D; Van Zee KJ; Pilewskie M
    Ann Surg Oncol; 2019 Dec; 26(13):4317-4325. PubMed ID: 31552614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
    Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
    Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
    Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.
    Hwang ES; Nyante SJ; Yi Chen Y; Moore D; DeVries S; Korkola JE; Esserman LJ; Waldman FM
    Cancer; 2004 Jun; 100(12):2562-72. PubMed ID: 15197797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
    Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
    Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.